Table 1. Demographic, neurological and freezing characteristics of subjects with and without freezing of gait.
Freezers (n = 17) | Non-freezers (n = 11) | |||||||
Mean ± SD | Median | Range | Mean ± SD | Median | Range | |||
Age | 66.1±6.5 | 66 | 25 | 63.4±8.1 | 64 | 30 | ||
Disease duration (yr.) | 7.24±3.7 | 7.0 | 25 | 5.55±3.1 | 4.0 | 11 | ||
LEDD | 807±549 | 800 | 2400 | 517±427 | 450 | 1350 | ||
H & Y | 1.88±0.4 | 2.0 | 1.5 | 1.77±0.6 | 2.0 | 1.5 | ||
UPDRS III | ‘Off’ | 32.4±11 | 36 | 40 | 22.2±11 | 24 | 38 | |
UPDRS III | ‘On’ | 24.2±14 | 22 | 44 | 12.5±6.7 | 11 | 19 | |
MMSE | 27.8±2.1 | 28 | 7.0 | 29.3±0.6 | 29 | 2.0 | ||
BDI-II | 13.9±11 | 14 | 42 | 7.45±6.5 | 4.0 | 18 | ||
Modal FSL | ‘Off’ | 0.42±0.2 | 0.37 | 0.55 | 0.47±0.2 | 0.44 | 0.57 | |
Modal FSL | ‘On’ | 0.46±0.1 | 0.49 | 0.50 | 0.46±0.1 | 0.44 | 0.44 | |
FOG-Q | 10.2±4.5 | 10 | 15 | 1.30±1.4 | 1.0 | 4.0 |
NOTE: H & Y = Hoehn and Yahr stages, UPDRS III = motor section of the Unified Parkinson’s Disease Rating Scale, LEDD = Levodopa Equivalent Daily Dose (mg/day), MMSE = Mini Mental State Examination, BDI-II = Beck’s Depression Inventory version II, Modal FSL = Modal Footstep Latency, FOG-Q = Freezing of Gait Questionnaire.